Seasoned Leader with Experience at Bristol-Myers
Squibb, Warner-Lambert, and Novartis to Lead
Financial Operations and Strategic Planning
BERKELEY HEIGHTS, NJ October 28, 2002 -
Genta Incorporated (Nasdaq: GNTA)
announces the appointment of William P. Keane as
Vice-President and Chief Financial Officer
(CFO). Mr. Keane brings more than twenty- five
years of experience in finance and management
within the pharmaceutical industry to Genta. Mr.
Keane will lead the company's Finance,
Strategic Planning, and Information Technology (IT)
groups at Genta, where he will report to the
Chief Executive Officer.
Mr. Keane most recently served as Vice President of
Sourcing, Strategy, and Operations
Effectiveness at Bristol Myers Squibb, Inc. In this
position, he oversaw the Technical
Operations unit that included Manufacturing,
Quality, Facilities, and Engineering. Mr. Keane
was also responsible for the integration of the
Manufacturing and Quality divisions of DuPont
Pharmaceuticals following its acquisition by
Bristol-Myers Squibb. From 2000 to 2001, he
served as CFO of Covance Biotechnology Services
Inc., where he worked towards the
divestiture of that company from Covance Inc. From
1997 to 2000, Mr. Keane served as Vice-
President of Finance within the Global
Manufacturing group at Warner-Lambert/Pfizer, where he
led the Finance and Systems groups that supported
the Global Manufacturing and Quality
functions of the Pharmaceuticals Sector. From 1985
to 1997, he held positions of increasing
responsibility in Finance and Operations at
Ciba-Geigy/Novartis. His positions included leading
the Finance, IT, Business Development, and
Administration functions of the U.K.
pharmaceuticals business of Novartis AG. Mr. Keane
also participated in the merger of Ciba-
Geigy with Sandoz to form Novartis.
Mr. Keane commented: "I'm very pleased to be
joining the extraordinarily experienced group of
senior managers at Genta, each of whom has
established strong track records of success in the
pharmaceutical industry."
"We are delighted to welcome Bill Keane onto our
team, an individual who combines strong
financial strength with extensive operational
experience in the pharmaceutical sector,"
commented Dr. Raymond P. Warrell, Genta's Chairman
and Chief Executive Officer. "Bill's
background in strategic planning, IT
implementation, and financial management will be a
tremendous asset to the Company as we begin
commercialization of our product portfolio."
